An Illinois city just stepped into the war against big pharma over drug pricing
Rockford, Illinois, is suing Mallinckrodt Pharmaceuticals over the price of the company’s drug Acthar, Business Insider reported.
Specifically, Rockford is accusing the drugmaker of taking advantage of its hold on the market and charging an excessive price for the drug, which is listed at about $35 000 for a vial.
The complaint said that “by establishing and maintain a monopoly, exercising monopoly power, and engaging in other unlawful acts and practices, the Defendants were able to extract exorbitant revenue from consumers that had nowhere else to turn for treatment.”
A company representative noted that “Mallinckrodt is aware of the lawsuit filed in the US District Court for the Northern District of Illinois,” adding that it “has received and is evaluating the complaint, and will consider its response after completing its assessment.”